Atlas Trials

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

Clinical trial NCT05131139 · UNKNOWN

Trial details

NCT number
NCT05131139
Sponsor
Senseonics, Inc.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2021-10-20
Primary completion
2025-03-30
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.